Internal Medicine, Gastroenterology · Crystal River, FL
NPI
1881623767
Since 2006
Specialty
Internal Medicine, Gastroenterology
Code 207RG0100X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
6410 W Gulf to Lake Hwy
Crystal River, FL, 34429
Phone (352) 563-2450
Groups this clinician bills Medicare through
Medicare paid, 2024
$366K
4,399 services
Medicare patients, 2024
992
Average age 75
Drug cost, 2024
$1.1M
2,251 prescriptions
Company payments, 2025
$1,480
From 16 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Sreekanth Chandrupatla was code 88305 (surgical pathology examination), 1,035 times for 408 patients. In total Sreekanth Chandrupatla billed 4,399 services in 52 codes, and Medicare paid $366K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2007-07-08.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 88305 Surgical Pathology Examination | Office | 1,035 | 408 | $54.99 | $57K |
| 99213 Office E&M - Established | Office | 934 | 573 | $66.16 | $62K |
| 88313 Surgical Pathology Examination | Office | 334 | 175 | $64.75 | $22K |
| 45385 Colonoscopy - Lesion Removal | Facility | 232 | 231 | $214.08 | $50K |
| 88312 Surgical Pathology Examination | Office | 224 | 134 | $88.15 | $20K |
| 43239 Upper GI Endoscopy | Facility | 215 | 203 | $77.93 | $17K |
| 99203 Office E&M - New | Office | 187 | 187 | $72.22 | $14K |
| 88360 Immunohistochemistry | Office | 170 | 100 | $94.54 | $16K |
| 99233 Hospital E&M - Subsequent | Facility | 144 | 90 | $96.48 | $14K |
| 88342 Immunohistochemistry | Office | 126 | 75 | $83.32 | $10K |
| 99223 Hospital E&M - Initial | Facility | 116 | 114 | $140.39 | $16K |
| 76700 Ultrasound - Abdomen and Pelvis | Office | 96 | 77 | $79.56 | $7,637 |
| 76981 Ultrasound - Nonspecific | Office | 79 | 75 | $72.21 | $5,705 |
| 99204 Office E&M - New | Office | 77 | 77 | $111.79 | $8,608 |
| 43248 Upper GI Endoscopy | Facility | 77 | 73 | $127.72 | $9,834 |
By year: 2022 $407K for 5,992 services; 2023 $398K for 4,866 services; 2024 $366K for 4,399 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 88305 Surgical Pathology Examination | 1,035 | 408 | $54.99 | $57K |
| 88313 Surgical Pathology Examination | 334 | 175 | $64.75 | $22K |
| 88312 Surgical Pathology Examination | 224 | 134 | $88.15 | $20K |
| 88360 Immunohistochemistry | 170 | 100 | $94.54 | $16K |
| 88342 Immunohistochemistry | 126 | 75 | $83.32 | $10K |
Medicare prescription drug claims, 2024
In 2024, the drug Sreekanth Chandrupatla prescribed most often to Medicare patients was Omeprazole, with 675 prescriptions and refills. In total Sreekanth Chandrupatla wrote 2,251 Medicare prescriptions that cost $1.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Omeprazole Generic | 675 | 1,532 | 237 | $9,128 |
| Clenpiq Sod Picosulf/Mag Ox/Citric Ac | 311 | 316 | 306 | $53K |
| Pantoprazole Sodium Generic | 221 | 534 | 85 | $3,749 |
| Gavilyte-G Peg3350/Sod Sulf,bicarb,cl/Kcl | 100 | 100 | 88 | $1,589 |
| Gavilyte-C Peg3350/Sod Sulf,bicarb,cl/Kcl | 80 | 80 | 79 | $1,418 |
| Colestipol Hcl Generic | 70 | 124 | 28 | $4,669 |
| Sucralfate Generic | 54 | 78 | 25 | $1,849 |
| Ondansetron Odt Ondansetron | 49 | 57 | 27 | $1,744 |
| Linzess Linaclotide | 47 | 95 | 17 | $49K |
| Creon Lipase/Protease/Amylase | 43 | 97 | 18 | $265K |
| Lactulose Generic | 38 | 56 | 25 | $1,172 |
| Mesalamine Generic | 31 | 63 | 11 | $31K |
| Xifaxan Rifaximin | 29 | 29 | Under 11 | $83K |
| Lubiprostone Generic | 27 | 35 | 12 | $2,771 |
| Famotidine Generic | 26 | 79 | 12 | $586 |
Brand drugs: 598 claims; generic drugs: 1,653 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Sreekanth Chandrupatla $1,480 ($1,480 in general payments such as food, travel and fees) from 16 companies. The largest payer was Janssen Biotech, Inc. with $405.
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. JNJ | 7 | $405 |
| Abbvie Inc. ABBV | 18 | $369 |
| Ipsen Biopharmaceuticals, Inc IPN.PA | 4 | $198 |
| Intercept Pharmaceuticals, Inc. | 1 | $113 |
| Edwards Lifesciences Corporation EW | 1 | $72.74 |
| Phathom Pharmaceuticals, Inc. PHAT | 11 | $55 |
| Genzyme Corporation SNY | 2 | $49.41 |
| Madrigal Pharmaceuticals MDGL | 2 | $39.83 |
| Novo Nordisk Inc NVO | 1 | $32.1 |
| Lilly USA, LLC LLY | 1 | $26.29 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.